Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Hemato Oncology Testing Market Insights, Forecast to 2030

Global Hemato Oncology Testing Market Insights, Forecast to 2030

Industry: Medical Devices & Consumables

Published Date: 2024-04-07

Pages: 114 Pages

Report ld: 2717607

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Hemato Oncology Testing is a technology to predict the probability of disease by collecting genes (DNA) in human blood and analyzing and measuring the complete sequence of genes. Genetic testing can identify individuals' genes for disease, thereby preventing or treating tumours earlier.

Hematologic tumor detection is a technique to detect tumor genes on the basis of gene detection. Blood tumor detection services cover a wide range of solid tumors such as lung cancer, breast cancer, stomach cancer, esophageal cancer, colorectal cancer and liver cancer. Common tumors are detected. According to different tumor stages, blood tumor detection can be divided into four categories: tumor susceptibility gene screening, tumor early diagnosis, tumor individualized drug diagnosis, and tumor recovery monitoring. Tumor susceptibility gene screening can help people at high risk of genetic mutations to actively prevent tumors. Early diagnosis of cancer can help patients to find the disease as early as possible, thus greatly improving the survival rate of cancer patients. Individualized drug diagnosis for cancer patients to provide a more accurate cancer treatment program. Tumor recovery was monitored to assess the risk of recurrence.

In this paper, the current status and future development trend of hematoncology testing in China market are studied, focusing on the analysis of the companies that play an important role in the Chinese market, and focusing on the revenue, market share, market positioning, development plans, products and services of these companies in the Chinese market.

Market Analysis and Insights: Global Hemato Oncology Testing Market

The global Hemato Oncology Testing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

In Chinese Market, Hemato Oncology Testing key players include Roche, Berry Genomics, Burning Rock Dx, BGI, Genetron, etc. Global top 5 manufacturers hold a share over 28%.

In terms of product, ctDNA Testing is the largest segment, with a share over 71%. And in terms of application, the largest application is Hospital, followed by Third Party Agency, Others.

Report Covers:

This report presents an overview of global market for Hemato Oncology Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Hemato Oncology Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Hemato Oncology Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hemato Oncology Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Hemato Oncology Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Hemato Oncology Testing revenue, projected growth trends, production technology, application and end-user industry.

MARKET SEGMENTATION

By Company

Roche
Berry Genomics
Burning Rock Dx
BGI
Genetron
Haplox
Amoy Dx
Genosaber
YZY Biopharma
Wondfo

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

ctDNA Testing
CTC Testing
Other Testing

Segment by Application

Hospital
Third Party Agency
Others

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hemato Oncology Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 ctDNA Testing

1.2.3 CTC Testing

1.2.4 Other Testing

1.3 Market by Application

1.3.1 Global Hemato Oncology Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Third Party Agency

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Hemato Oncology Testing Market Perspective (2019-2030)

2.2 Global Hemato Oncology Testing Growth Trends by Region

2.2.1 Hemato Oncology Testing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Hemato Oncology Testing Historic Market Size by Region (2019-2024)

2.2.3 Hemato Oncology Testing Forecasted Market Size by Region (2025-2030)

2.3 Hemato Oncology Testing Market Dynamics

2.3.1 Hemato Oncology Testing Industry Trends

2.3.2 Hemato Oncology Testing Market Drivers

2.3.3 Hemato Oncology Testing Market Challenges

2.3.4 Hemato Oncology Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Hemato Oncology Testing by Players

3.1.1 Global Hemato Oncology Testing Revenue by Players (2019-2024)

3.1.2 Global Hemato Oncology Testing Revenue Market Share by Players (2019-2024)

3.2 Global Hemato Oncology Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Hemato Oncology Testing, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Hemato Oncology Testing Market Concentration Ratio

3.4.1 Global Hemato Oncology Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hemato Oncology Testing Revenue in 2023

3.5 Global Key Players of Hemato Oncology Testing Head office and Area Served

3.6 Global Key Players of Hemato Oncology Testing, Product and Application

3.7 Global Key Players of Hemato Oncology Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Hemato Oncology Testing Breakdown Data by Type

4.1 Global Hemato Oncology Testing Historic Market Size by Type (2019-2024)

4.2 Global Hemato Oncology Testing Forecasted Market Size by Type (2025-2030)

5 Hemato Oncology Testing Breakdown Data by Application

5.1 Global Hemato Oncology Testing Historic Market Size by Application (2019-2024)

5.2 Global Hemato Oncology Testing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Hemato Oncology Testing Market Size (2019-2030)

6.2 North America Hemato Oncology Testing Market Size by Type

6.2.1 North America Hemato Oncology Testing Market Size by Type (2019-2024)

6.2.2 North America Hemato Oncology Testing Market Size by Type (2025-2030)

6.2.3 North America Hemato Oncology Testing Market Share by Type (2019-2030)

6.3 North America Hemato Oncology Testing Market Size by Application

6.3.1 North America Hemato Oncology Testing Market Size by Application (2019-2024)

6.3.2 North America Hemato Oncology Testing Market Size by Application (2025-2030)

6.3.3 North America Hemato Oncology Testing Market Share by Application (2019-2030)

6.4 North America Hemato Oncology Testing Market Size by Country

6.4.1 North America Hemato Oncology Testing Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Hemato Oncology Testing Market Size by Country (2019-2024)

6.4.3 North America Hemato Oncology Testing Market Size by Country (2025-2030)

6.4.4 United States

6.4.5 Canada

7 Europe

7.1 Europe Hemato Oncology Testing Market Size (2019-2030)

7.2 Europe Hemato Oncology Testing Market Size by Type

7.2.1 Europe Hemato Oncology Testing Market Size by Type (2019-2024)

7.2.2 Europe Hemato Oncology Testing Market Size by Type (2025-2030)

7.2.3 Europe Hemato Oncology Testing Market Share by Type (2019-2030)

7.3 Europe Hemato Oncology Testing Market Size by Application

7.3.1 Europe Hemato Oncology Testing Market Size by Application (2019-2024)

7.3.2 Europe Hemato Oncology Testing Market Size by Application (2025-2030)

7.3.3 Europe Hemato Oncology Testing Market Share by Application (2019-2030)

7.4 Europe Hemato Oncology Testing Market Size by Country

7.4.1 Europe Hemato Oncology Testing Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Hemato Oncology Testing Market Size by Country (2019-2024)

7.4.3 Europe Hemato Oncology Testing Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Hemato Oncology Testing Market Size (2019-2030)

8.2 China Hemato Oncology Testing Market Size by Type

8.2.1 China Hemato Oncology Testing Market Size by Type (2019-2024)

8.2.2 China Hemato Oncology Testing Market Size by Type (2025-2030)

8.2.3 China Hemato Oncology Testing Market Share by Type (2019-2030)

8.3 China Hemato Oncology Testing Market Size by Application

8.3.1 China Hemato Oncology Testing Market Size by Application (2019-2024)

8.3.2 China Hemato Oncology Testing Market Size by Application (2025-2030)

8.3.3 China Hemato Oncology Testing Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Hemato Oncology Testing Market Size (2019-2030)

9.2 Asia Hemato Oncology Testing Market Size by Type

9.2.1 Asia Hemato Oncology Testing Market Size by Type (2019-2024)

9.2.2 Asia Hemato Oncology Testing Market Size by Type (2025-2030)

9.2.3 Asia Hemato Oncology Testing Market Share by Type (2019-2030)

9.3 Asia Hemato Oncology Testing Market Size by Application

9.3.1 Asia Hemato Oncology Testing Market Size by Application (2019-2024)

9.3.2 Asia Hemato Oncology Testing Market Size by Application (2025-2030)

9.3.3 Asia Hemato Oncology Testing Market Share by Application (2019-2030)

9.4 Asia Hemato Oncology Testing Market Size by Region

9.4.1 Asia Hemato Oncology Testing Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Hemato Oncology Testing Market Size by Region (2019-2024)

9.4.3 Asia Hemato Oncology Testing Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Hemato Oncology Testing Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Hemato Oncology Testing Market Size by Type

10.2.1 Middle East, Africa, and Latin America Hemato Oncology Testing Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Hemato Oncology Testing Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Hemato Oncology Testing Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Hemato Oncology Testing Market Size by Application

10.3.1 Middle East, Africa, and Latin America Hemato Oncology Testing Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Hemato Oncology Testing Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Hemato Oncology Testing Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Hemato Oncology Testing Market Size by Country

10.4.1 Middle East, Africa, and Latin America Hemato Oncology Testing Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Hemato Oncology Testing Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Hemato Oncology Testing Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Hemato Oncology Testing Introduction

11.1.4 Roche Revenue in Hemato Oncology Testing Business (2019-2024)

11.1.5 Roche Recent Developments

11.2 Berry Genomics

11.2.1 Berry Genomics Company Details

11.2.2 Berry Genomics Business Overview

11.2.3 Berry Genomics Hemato Oncology Testing Introduction

11.2.4 Berry Genomics Revenue in Hemato Oncology Testing Business (2019-2024)

11.2.5 Berry Genomics Recent Developments

11.3 Burning Rock Dx

11.3.1 Burning Rock Dx Company Details

11.3.2 Burning Rock Dx Business Overview

11.3.3 Burning Rock Dx Hemato Oncology Testing Introduction

11.3.4 Burning Rock Dx Revenue in Hemato Oncology Testing Business (2019-2024)

11.3.5 Burning Rock Dx Recent Developments

11.4 BGI

11.4.1 BGI Company Details

11.4.2 BGI Business Overview

11.4.3 BGI Hemato Oncology Testing Introduction

11.4.4 BGI Revenue in Hemato Oncology Testing Business (2019-2024)

11.4.5 BGI Recent Developments

11.5 Genetron

11.5.1 Genetron Company Details

11.5.2 Genetron Business Overview

11.5.3 Genetron Hemato Oncology Testing Introduction

11.5.4 Genetron Revenue in Hemato Oncology Testing Business (2019-2024)

11.5.5 Genetron Recent Developments

11.6 Haplox

11.6.1 Haplox Company Details

11.6.2 Haplox Business Overview

11.6.3 Haplox Hemato Oncology Testing Introduction

11.6.4 Haplox Revenue in Hemato Oncology Testing Business (2019-2024)

11.6.5 Haplox Recent Developments

11.7 Amoy Dx

11.7.1 Amoy Dx Company Details

11.7.2 Amoy Dx Business Overview

11.7.3 Amoy Dx Hemato Oncology Testing Introduction

11.7.4 Amoy Dx Revenue in Hemato Oncology Testing Business (2019-2024)

11.7.5 Amoy Dx Recent Developments

11.8 Genosaber

11.8.1 Genosaber Company Details

11.8.2 Genosaber Business Overview

11.8.3 Genosaber Hemato Oncology Testing Introduction

11.8.4 Genosaber Revenue in Hemato Oncology Testing Business (2019-2024)

11.8.5 Genosaber Recent Developments

11.9 YZY Biopharma

11.9.1 YZY Biopharma Company Details

11.9.2 YZY Biopharma Business Overview

11.9.3 YZY Biopharma Hemato Oncology Testing Introduction

11.9.4 YZY Biopharma Revenue in Hemato Oncology Testing Business (2019-2024)

11.9.5 YZY Biopharma Recent Developments

11.10 Wondfo

11.10.1 Wondfo Company Details

11.10.2 Wondfo Business Overview

11.10.3 Wondfo Hemato Oncology Testing Introduction

11.10.4 Wondfo Revenue in Hemato Oncology Testing Business (2019-2024)

11.10.5 Wondfo Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Hemato Oncology Testing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of ctDNA Testing

Table 3. Key Players of CTC Testing

Table 4. Key Players of Other Testing

Table 5. Global Hemato Oncology Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Hemato Oncology Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Hemato Oncology Testing Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Hemato Oncology Testing Market Share by Region (2019-2024)

Table 9. Global Hemato Oncology Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Hemato Oncology Testing Market Share by Region (2025-2030)

Table 11. Hemato Oncology Testing Market Trends

Table 12. Hemato Oncology Testing Market Drivers

Table 13. Hemato Oncology Testing Market Challenges

Table 14. Hemato Oncology Testing Market Restraints

Table 15. Global Hemato Oncology Testing Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Hemato Oncology Testing Revenue Share by Players (2019-2024)

Table 17. Global Top Hemato Oncology Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemato Oncology Testing as of 2023)

Table 18. Global Hemato Oncology Testing Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Hemato Oncology Testing Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Hemato Oncology Testing, Headquarters and Area Served

Table 21. Global Key Players of Hemato Oncology Testing, Product and Application

Table 22. Global Key Players of Hemato Oncology Testing, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Hemato Oncology Testing Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Hemato Oncology Testing Revenue Market Share by Type (2019-2024)

Table 26. Global Hemato Oncology Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Hemato Oncology Testing Revenue Market Share by Type (2025-2030)

Table 28. Global Hemato Oncology Testing Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Hemato Oncology Testing Revenue Share by Application (2019-2024)

Table 30. Global Hemato Oncology Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Hemato Oncology Testing Revenue Share by Application (2025-2030)

Table 32. North America Hemato Oncology Testing Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Hemato Oncology Testing Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Hemato Oncology Testing Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Hemato Oncology Testing Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Hemato Oncology Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Hemato Oncology Testing Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Hemato Oncology Testing Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Hemato Oncology Testing Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Hemato Oncology Testing Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Hemato Oncology Testing Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Hemato Oncology Testing Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Hemato Oncology Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Hemato Oncology Testing Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Hemato Oncology Testing Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Hemato Oncology Testing Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Hemato Oncology Testing Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Hemato Oncology Testing Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Hemato Oncology Testing Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Hemato Oncology Testing Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Hemato Oncology Testing Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Hemato Oncology Testing Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Hemato Oncology Testing Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Hemato Oncology Testing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Hemato Oncology Testing Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Hemato Oncology Testing Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Hemato Oncology Testing Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Hemato Oncology Testing Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Hemato Oncology Testing Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Hemato Oncology Testing Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Hemato Oncology Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Hemato Oncology Testing Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Hemato Oncology Testing Market Size by Country (2025-2030) & (US$ Million)

Table 64. Roche Company Details

Table 65. Roche Business Overview

Table 66. Roche Hemato Oncology Testing Product

Table 67. Roche Revenue in Hemato Oncology Testing Business (2019-2024) & (US$ Million)

Table 68. Roche Recent Developments

Table 69. Berry Genomics Company Details

Table 70. Berry Genomics Business Overview

Table 71. Berry Genomics Hemato Oncology Testing Product

Table 72. Berry Genomics Revenue in Hemato Oncology Testing Business (2019-2024) & (US$ Million)

Table 73. Berry Genomics Recent Developments

Table 74. Burning Rock Dx Company Details

Table 75. Burning Rock Dx Business Overview

Table 76. Burning Rock Dx Hemato Oncology Testing Product

Table 77. Burning Rock Dx Revenue in Hemato Oncology Testing Business (2019-2024) & (US$ Million)

Table 78. Burning Rock Dx Recent Developments

Table 79. BGI Company Details

Table 80. BGI Business Overview

Table 81. BGI Hemato Oncology Testing Product

Table 82. BGI Revenue in Hemato Oncology Testing Business (2019-2024) & (US$ Million)

Table 83. BGI Recent Developments

Table 84. Genetron Company Details

Table 85. Genetron Business Overview

Table 86. Genetron Hemato Oncology Testing Product

Table 87. Genetron Revenue in Hemato Oncology Testing Business (2019-2024) & (US$ Million)

Table 88. Genetron Recent Developments

Table 89. Haplox Company Details

Table 90. Haplox Business Overview

Table 91. Haplox Hemato Oncology Testing Product

Table 92. Haplox Revenue in Hemato Oncology Testing Business (2019-2024) & (US$ Million)

Table 93. Haplox Recent Developments

Table 94. Amoy Dx Company Details

Table 95. Amoy Dx Business Overview

Table 96. Amoy Dx Hemato Oncology Testing Product

Table 97. Amoy Dx Revenue in Hemato Oncology Testing Business (2019-2024) & (US$ Million)

Table 98. Amoy Dx Recent Developments

Table 99. Genosaber Company Details

Table 100. Genosaber Business Overview

Table 101. Genosaber Hemato Oncology Testing Product

Table 102. Genosaber Revenue in Hemato Oncology Testing Business (2019-2024) & (US$ Million)

Table 103. Genosaber Recent Developments

Table 104. YZY Biopharma Company Details

Table 105. YZY Biopharma Business Overview

Table 106. YZY Biopharma Hemato Oncology Testing Product

Table 107. YZY Biopharma Revenue in Hemato Oncology Testing Business (2019-2024) & (US$ Million)

Table 108. YZY Biopharma Recent Developments

Table 109. Wondfo Company Details

Table 110. Wondfo Business Overview

Table 111. Wondfo Hemato Oncology Testing Product

Table 112. Wondfo Revenue in Hemato Oncology Testing Business (2019-2024) & (US$ Million)

Table 113. Wondfo Recent Developments

Table 114. Research Programs/Design for This Report

Table 115. Key Data Information from Secondary Sources

Table 116. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Hemato Oncology Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Hemato Oncology Testing Market Share by Type: 2023 VS 2030

Figure 3. ctDNA Testing Features

Figure 4. CTC Testing Features

Figure 5. Other Testing Features

Figure 6. Global Hemato Oncology Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Hemato Oncology Testing Market Share by Application: 2023 VS 2030

Figure 8. Hospital Case Studies

Figure 9. Third Party Agency Case Studies

Figure 10. Others Case Studies

Figure 11. Hemato Oncology Testing Report Years Considered

Figure 12. Global Hemato Oncology Testing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Hemato Oncology Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Hemato Oncology Testing Market Share by Region: 2023 VS 2030

Figure 15. Global Hemato Oncology Testing Market Share by Players in 2023

Figure 16. Global Top Hemato Oncology Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemato Oncology Testing as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Hemato Oncology Testing Revenue in 2023

Figure 18. North America Hemato Oncology Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Hemato Oncology Testing Market Share by Type (2019-2030)

Figure 20. North America Hemato Oncology Testing Market Share by Application (2019-2030)

Figure 21. North America Hemato Oncology Testing Market Share by Country (2019-2030)

Figure 22. United States Hemato Oncology Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Hemato Oncology Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Hemato Oncology Testing Market Size YoY (2019-2030) & (US$ Million)

Figure 25. Europe Hemato Oncology Testing Market Share by Type (2019-2030)

Figure 26. Europe Hemato Oncology Testing Market Share by Application (2019-2030)

Figure 27. Europe Hemato Oncology Testing Market Share by Country (2019-2030)

Figure 28. Germany Hemato Oncology Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Hemato Oncology Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Hemato Oncology Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Hemato Oncology Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Hemato Oncology Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Hemato Oncology Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Hemato Oncology Testing Market Size YoY (2019-2030) & (US$ Million)

Figure 35. China Hemato Oncology Testing Market Share by Type (2019-2030)

Figure 36. China Hemato Oncology Testing Market Share by Application (2019-2030)

Figure 37. Asia Hemato Oncology Testing Market Size YoY (2019-2030) & (US$ Million)

Figure 38. Asia Hemato Oncology Testing Market Share by Type (2019-2030)

Figure 39. Asia Hemato Oncology Testing Market Share by Application (2019-2030)

Figure 40. Asia Hemato Oncology Testing Market Share by Region (2019-2030)

Figure 41. Japan Hemato Oncology Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Hemato Oncology Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Hemato Oncology Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Hemato Oncology Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Hemato Oncology Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Hemato Oncology Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Hemato Oncology Testing Market Size YoY (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Hemato Oncology Testing Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Hemato Oncology Testing Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Hemato Oncology Testing Market Share by Country (2019-2030)

Figure 51. Brazil Hemato Oncology Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Hemato Oncology Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Hemato Oncology Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Hemato Oncology Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Hemato Oncology Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Hemato Oncology Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Roche Revenue Growth Rate in Hemato Oncology Testing Business (2019-2024)

Figure 58. Berry Genomics Revenue Growth Rate in Hemato Oncology Testing Business (2019-2024)

Figure 59. Burning Rock Dx Revenue Growth Rate in Hemato Oncology Testing Business (2019-2024)

Figure 60. BGI Revenue Growth Rate in Hemato Oncology Testing Business (2019-2024)

Figure 61. Genetron Revenue Growth Rate in Hemato Oncology Testing Business (2019-2024)

Figure 62. Haplox Revenue Growth Rate in Hemato Oncology Testing Business (2019-2024)

Figure 63. Amoy Dx Revenue Growth Rate in Hemato Oncology Testing Business (2019-2024)

Figure 64. Genosaber Revenue Growth Rate in Hemato Oncology Testing Business (2019-2024)

Figure 65. YZY Biopharma Revenue Growth Rate in Hemato Oncology Testing Business (2019-2024)

Figure 66. Wondfo Revenue Growth Rate in Hemato Oncology Testing Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Hemato Oncology Testing market? zhanKai

The top companies in the global Hemato Oncology Testing market are Roche、Berry Genomics、Burning Rock Dx.

Related Reports

Global Hemato Oncology Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemato Oncology Testing market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 79
USD 4250.00
(Single User License)
Global Hemato Oncology Testing Market Research Report 2026
The global Hemato Oncology Testing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-05
Pages: 102
USD 2900.00
(Single User License)
Hemato Oncology Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemato Oncology Testing was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-05
Pages: 86
USD 3950.00
(Single User License)
Global Hemato Oncology Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemato Oncology Testing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 78
USD 4250.00
(Single User License)
Global Hemato Oncology Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemato Oncology Testing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-08
Pages: 126
USD 4900.00
(Single User License)
Hemato Oncology Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemato Oncology Testing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 94
USD 3950.00
(Single User License)
Global Hemato Oncology Testing Market Research Report 2025
The global market for Hemato Oncology Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-19
Pages: 73
USD 2900.00
(Single User License)
Global Hemato Oncology Testing Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemato Oncology Testing is a technology to predict the probability of disease by collecting genes (DNA) in human blood and analyzing and measuring the complete sequence of genes. Genetic testing can identify individuals' genes for disease, thereby preventing or treating tumours earlier.
Published Date: 2024-04-17
Pages: 155
USD 5600.00
(Single User License)
Global Hemato Oncology Testing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemato Oncology Testing is a technology to predict the probability of disease by collecting genes (DNA) in human blood and analyzing and measuring the complete sequence of genes. Genetic testing can identify individuals' genes for disease, thereby preventing or treating tumours earlier.
Published Date: 2024-04-16
Pages: 151
USD 5900.00
(Single User License)
Hemato Oncology Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Hemato Oncology Testing is a technology to predict the probability of disease by collecting genes (DNA) in human blood and analyzing and measuring the complete sequence of genes. Genetic testing can identify individuals' genes for disease, thereby preventing or treating tumours earlier.
Published Date: 2024-01-18
Pages: 103
USD 3950.00
(Single User License)

Global Hemato Oncology Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemato Oncology Testing market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 79
USD 4250.00 (Single User License)
Global Hemato Oncology Testing Market Research Report 2026
The global Hemato Oncology Testing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-05
Pages: 102
USD 2900.00 (Single User License)
Hemato Oncology Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemato Oncology Testing was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-05
Pages: 86
USD 3950.00 (Single User License)
Global Hemato Oncology Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemato Oncology Testing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 78
USD 4250.00 (Single User License)
Global Hemato Oncology Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemato Oncology Testing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-08
Pages: 126
USD 4900.00 (Single User License)
Hemato Oncology Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemato Oncology Testing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 94
USD 3950.00 (Single User License)
Global Hemato Oncology Testing Market Research Report 2025
The global market for Hemato Oncology Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-19
Pages: 73
USD 2900.00 (Single User License)
Global Hemato Oncology Testing Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemato Oncology Testing is a technology to predict the probability of disease by collecting genes (DNA) in human blood and analyzing and measuring the complete sequence of genes. Genetic testing can identify individuals' genes for disease, thereby preventing or treating tumours earlier.
Published: 2024-04-17
Pages: 155
USD 5600.00 (Single User License)
Global Hemato Oncology Testing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemato Oncology Testing is a technology to predict the probability of disease by collecting genes (DNA) in human blood and analyzing and measuring the complete sequence of genes. Genetic testing can identify individuals' genes for disease, thereby preventing or treating tumours earlier.
Published: 2024-04-16
Pages: 151
USD 5900.00 (Single User License)
Hemato Oncology Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Hemato Oncology Testing is a technology to predict the probability of disease by collecting genes (DNA) in human blood and analyzing and measuring the complete sequence of genes. Genetic testing can identify individuals' genes for disease, thereby preventing or treating tumours earlier.
Published: 2024-01-18
Pages: 103
USD 3950.00 (Single User License)